Advancing innovation in accelerated cancer diagnosis

Advancing innovation in accelerated cancer diagnosis is a UK competition to support the clinical validation and evaluation of early cancer diagnostic technologies and devices. Innovate UK, on behalf of the OLS Cancer Healthcare Goals programme, will invest up to £25.4 million in successful projects. The competition is for collaborative consortia led by eligible UK organisations and requires participation by at least one UK micro, small or medium sized enterprise claiming grant funding. Projects should focus on technologies and devices for earlier cancer diagnosis and clinical validation.

Grant funding to support clinical validation and evaluation of diagnostic technologies and devices (total investment up to £25.4 million).

This competition is open to collaborations only. To lead a collaborative project your organisation must be a UK registered business, an academic institution, or an NHS organisation. The consortium must contain at least one UK registered micro, small or medium sized enterprise claiming grant funding on this application.

Projects must be led by an eligible UK organisation and include a UK SME claiming grant funding.